Federated Hermes
LUMO

Federated Hermes’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Federated Hermes’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-334
Closed -$12K – 2362
2020
Q4 		$12K Sell
334
-121
-27% -$2.09K ﹤0.01% 1961
2020
Q3 		$6K Buy
455
+342
+303% +$5.11K ﹤0.01% 2014
2020
Q2 		$2K Buy
113
+11
+11% +$131 ﹤0.01% 2104
2020
Q1 		$1K Sell
102
-57
-36% -$797 ﹤0.01% 2167
2019
Q4 		$4K Hold
159
– – ﹤0.01% 1985
2019
Q3 		$2K Hold
159
– – ﹤0.01% 2046
2019
Q2 		$2K Sell
159
-6
-4% -$91 ﹤0.01% 2085
2019
Q1 		$3K Sell
165
-59
-26% -$880 ﹤0.01% 2045
2018
Q4 		$3K Sell
224
-169
-43% -$2.98K ﹤0.01% 2058
2018
Q3 		$8K Sell
393
-140
-26% -$4.26K ﹤0.01% 1990
2018
Q2 		$23K Sell
533
-820
-61% -$37.6K ﹤0.01% 1789
2018
Q1 		$88K Sell
1,353
-577
-30% -$40.9K ﹤0.01% 1607
2017
Q4 		$141K Sell
1,930
-248
-11% -$20.5K ﹤0.01% 1561
2017
Q3 		$200K Sell
2,178
-5,942
-73% -$456K ﹤0.01% 1498
2017
Q2 		$537K Buy
8,120
+1,352
+20% +$167K ﹤0.01% 1367
2017
Q1 		$1.47M Sell
6,768
-2,025
-23% -$289K ﹤0.01% 1036
2016
Q4 		$814K Sell
8,793
-4,605
-34% -$519K ﹤0.01% 1191
2016
Q3 		$1.81M Sell
13,398
-926
-6% -$92K 0.01% 890
2016
Q2 		$1.45M Buy
14,324
+8,098
+130% +$1M ﹤0.01% 972
2016
Q1 		$1.02M Buy
6,226
+6,220
+103,667% +$1.26M ﹤0.01% 1072
2015
Q4 		$2K Sell
6
-819
-99% -$267K ﹤0.01% 1975
2015
Q3 		$266K Sell
825
-52
-6% -$22.8K ﹤0.01% 1445
2015
Q2 		$350K Sell
877
-239
-21% -$102K ﹤0.01% 1406
2015
Q1 		$549K Buy
1,116
+105
+10% +$40.7K ﹤0.01% 1341
2014
Q4 		$362K Buy
+1,011
New +$301K ﹤0.01% 1411

Other funds holding LUMO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes's LUMO Position: Q1 2021 in Review

Federated Hermes sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2021, closing a stake of 334 shares — an estimated $12K sold.

Federated Hermes first reported a position in LUMO in Q4 2014 and held it in 25 quarters. The position peaked at $1.81M in Q3 2016. 41 funds tracked by Wall St. Rank hold LUMO as of Q1 2021.

  • Federated Hermes reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Federated Hermes sold 334 Lumos Pharma, Inc. Common Stock shares in Q1 2021, an estimated $12K.
  • Federated Hermes first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 25 quarters.
  • Federated Hermes's Lumos Pharma, Inc. Common Stock position peaked at $1.81M in Q3 2016.
  • 41 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2021.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.